176 related articles for article (PubMed ID: 27422008)
1. Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.
Chen YC; Liao JW; Hsu WL; Chang SC
BMC Vet Res; 2016 Jul; 12(1):142. PubMed ID: 27422008
[TBL] [Abstract][Full Text] [Related]
2. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
4. Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas.
Murakami M; Sakai H; Kodama A; Yanai T; Mori T; Maruo K; Masegi T
Histol Histopathol; 2009 Apr; 24(4):437-46. PubMed ID: 19224446
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours.
Abou Asa S; Mori T; Maruo K; Khater A; El-Sawak A; Abd el-Aziz E; Yanai T; Sakai H
Vet Comp Oncol; 2015 Sep; 13(3):237-45. PubMed ID: 23611531
[TBL] [Abstract][Full Text] [Related]
6. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors.
Webster JD; Kiupel M; Yuzbasiyan-Gurkan V
BMC Cancer; 2006 Apr; 6():85. PubMed ID: 16579858
[TBL] [Abstract][Full Text] [Related]
8. KIT gene exon 11 mutations in canine malignant melanoma.
Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
[TBL] [Abstract][Full Text] [Related]
9. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours.
Murakami M; Sakai H; Kodama A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2008 Jul; 139(1):1-7. PubMed ID: 18479697
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
13. Identification of isoforms and RH mapping of canine KIT.
Tsai KL; Guyon R; Murphy KE
Cytogenet Genome Res; 2003; 102(1-4):261-3. PubMed ID: 14970713
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed.
Tamburini BA; Trapp S; Phang TL; Schappa JT; Hunter LE; Modiano JF
PLoS One; 2009 May; 4(5):e5549. PubMed ID: 19461996
[TBL] [Abstract][Full Text] [Related]
16. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
[TBL] [Abstract][Full Text] [Related]
17. Expression of Hematopoietic Stem and Endothelial Cell Markers in Canine Hemangiosarcoma.
Kakiuchi-Kiyota S; Obert LA; Crowell DM; Xia S; Roy MD; Coskran TM; Kreeger JM; Crabbs TA; Cohen SM; Cattley RC; Cook JC
Toxicol Pathol; 2020 Apr; 48(3):481-493. PubMed ID: 31918642
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 and pp53 Ser
García-Iglesias MJ; Cuevas-Higuera JL; Bastida-Sáenz A; de Garnica-García MG; Polledo L; Perero P; González-Fernández J; Fernández-Martínez B; Pérez-Martínez C
BMC Vet Res; 2020 Jul; 16(1):239. PubMed ID: 32660487
[TBL] [Abstract][Full Text] [Related]
20. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]